SAN FRANCISCO The tricuspid valve has emerged as the setting for one of the next big chapters in transcatheter heart valve intervention, now that the aortic and mitral valve plotlines are so well developed.
In an international registry study, high-surgical-risk patients with symptomatic tricuspid regurgitation (TR) lived longer and were hospitalized less for heart failure (HF) if they underwent transcatheter treatment, compared with solely medical therapy.
Procedural success was key to the better outcomes of transcatheter tricuspid valve intervention (TTVI) in the casecontrol study with propensity matching. Such success was defined as survival with technically successful implantation and a significant reduction in TR.
Outcomes for those with unsuccessful procedures were about the same as for those managed with meds only.
The 1-year risk for death or HF hospitalization fell 40% (P= .003) and for mortality alone by 44% (P= .001) for the patients who underwent TTVI, achieved with the MitraClip (Abbott Vascular) in 85% of cases. The benefit was more pronounced when propensity matching was supplemented with further adjustment, including for atrial fibrillation (AF) and HF symptom status.
Maurizio Taramasso
On the basis of these findings, TTVI can be recommended for symptomatic patients with TR, "but it should be performed in selected patients and at high-volume centers" by dedicated interventional teams with a lot of TTVI experience, Maurizio Taramasso, MD, PhD, told theheart.org| Medscape Cardiology.
Surgery for TR carries a high mortality risk, up to 15%, in part because the valve dysfunction tends to be very advanced by the time of referral to a surgeon, observed Taramasso, from University Hospital of Zurich.
But TTVI "is pretty safe, the rate of complications is really low. I'm not saying we should treat all patients, but we should be more prone to offer this kind of therapy even at a bit earlier stage." he said.
Taramasso presented the analysis here at Transcatheter Cardiovascular Therapeutics 2019 and is lead author on its same-day publication in the Journal of the American College of Cardiology.
Much progressive TR is thought to be secondary to mitral valve dysfunction, and "surgeons have a really low threshold for repairing the tricuspid valve at the time of mitral valve repair," observed Robert Bonow, MD, Northwestern University, Chicago.
But their threshold for isolated tricuspid valve surgery in such patients with advanced-stage TR is much higher, agreed Bonow, not connected with the current analysis.
"The surgeons lament that these patients are coming in too late," he said. "So the idea is to get this before the horse is out of the barn, at a lower stage." And that's where the field is heading, "to identify these patients early to treat them before they get this sick."
Correction of TR by transcatheter techniques could extend the treatment to more patients. But the current study has big limitations, Bonow said. "I don't want to minimize the importance of the observations, but it's not a perfect study. At least they're showing you can improve TR, and when you do that kind of comparison, the outcomes are not bad. But the outcomes are still not great; it's just that they're better than medical therapy."
There is also a big potential for unknown confounders. "The lack of a contemporaneous control does weaken the analysis," Bonow said.
The study was based on patients in Europe and North America in the Transcatheter Tricuspid Valve Therapies (TriValve) registry who underwent TTVI over a recent 2-year period. They received the MitraClip, but also FORMA, Cardioband, Trialign, PASCAL (all Edwards Lifesciences), TriCinch (4TECH), and NaviGate (NaviGate Cardiac Structures) devices.
Matched pairs were created from 268 TriValve patients and an equal number of patients from two large retrospective registries of patients in Europe and North America with at least moderate TR managed with medical therapy only. Matching was based on age, EuroscoreII scores, and systolic pulmonary artery (PA) pressure.
Despite the matching, patients in the TTVI cohort from the matched pairs were more often men; had significantly more chronic AF, implanted devices with a lead positioned across the tricuspid valve, right ventricular dysfunction, and higher PA pressure; and had more advanced heart failure.
Mortality at 1 year was 22.6% for TTVI patients and 36.2% for medically managed patients (P= .0009) over a mean of 11 months. The HF rehospitalization rates were 26% and 47% (P< .0001), respectively.
One or both of those end points occurred in 32% and 49% of patients, respectively (P= .0003), for a primary composite end point hazard ratio (HR) of 0.60 (95% CI, 0.46- 0.79; P= .003).
Because the matched pairs weren't always well matched for other potential confounders, Taramasso said, the analysis was adjusted further for sex, NYHA functional class, right ventricular function, AF, mitral regurgitation, and use of an implantable pacemaker or defibrillator.
In that analysis, the primary end point HR was 0.35 (95% CI, 0.23- 0.54; P < .0001), and HR for any-cause death was 0.38 (95% CI, 0.23- 0.63; P= .002).
That the TTVI half of the matched patient pairs were sicker than those medically managed may improve the study's strength, AjayM. Kirtane, MD, Columbia University and New York-Presbyterian Hospital/Columbia University, New York City, said at a media briefing on the analysis.
Selection bias can be common in an observational study, he said; there can be questions about why a particular management strategy was chosen for individual patients, especially if the strategy under scrutiny involves an established device.
"With a mature technology, you worry sometimes with these comparisons that if you show a benefit of the technology, if might just be that the patients who weren't treated were sicker," Kirtane said. But the reverse was true here, so the findings are "more reassuring than otherwise."
The better outcomes in the sicker intervention group "is even further argument" in favor of TTVI over medical management in such patients, Taramasso agreed when speaking with theheart.org| Medscape Cardiology.
"Of course" there was some unavoidable selection bias, he said. But the different outcomes "all go in the same direction," and not only for symptomatic patients.
Taramasso discloses consulting for Abbott Vascular, Boston Scientific, 4TECH, and CoreMedic; and receiving speaker honoraria from Edwards Lifesciences. Bonow has previously disclosed no relevant financial relationships. Kirtane discloses receiving institutional funding from Medtronic, Boston Scientific Corporation, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, and ReCor Medical.
J Am Coll Cardiol. Published online September27, 2019. Abstract
Transcatheter Cardiovascular Therapeutics (TCT) 2019: Late Breaking Science2. Presented September27, 2019.
Follow Steve Stiles on Twitter: @SteveStiles2. For more from theheart.org| Medscape Cardiology, follow us on Twitter and Facebook.
Originally posted here:
Transcatheter Tricuspid Fix Bests Meds Alone in Early Results - Medscape
- Home - MedStar Heart & Vascular Institute - April 16th, 2018 [April 16th, 2018]
- Guidelines for Standards in Cardiac Surgery - April 16th, 2018 [April 16th, 2018]
- Cardiac Surgery - University of Ottawa Heart Institute - June 16th, 2018 [June 16th, 2018]
- Cardiac Surgery | UNC Medical Center, Hospitals Chapel ... - June 18th, 2018 [June 18th, 2018]
- Heart Surgery | Seattle Childrens Hospital - June 18th, 2018 [June 18th, 2018]
- Pediatric Cardiac Surgery | CHKD | Norfolk, VA - June 18th, 2018 [June 18th, 2018]
- Cardiac Surgery | McLaren Port Huron - July 4th, 2018 [July 4th, 2018]
- CardioVascular Thoracic Institute (CVTI) | The most ... - July 23rd, 2018 [July 23rd, 2018]
- Top Cardiac Surgery COST in India| Benefit - IndianHealthGuru - July 27th, 2018 [July 27th, 2018]
- Cardiac Surgery - Atrial Septal Defect - August 6th, 2018 [August 6th, 2018]
- Cardiac Surgery | Stony Brook Medicine - August 6th, 2018 [August 6th, 2018]
- Cardiac Surgery in the Adult Fifth Edition: Lawrence H. Cohn ... - August 6th, 2018 [August 6th, 2018]
- Pioneers of Cardiac Surgery: 9780826515940: Medicine & Health ... - August 6th, 2018 [August 6th, 2018]
- Cardiovascular Surgery Department | Cleveland Clinic - August 6th, 2018 [August 6th, 2018]
- Cardiac Surgery - Massachusetts General Hospital, Boston, MA - September 19th, 2018 [September 19th, 2018]
- Cardiac Surgery | Surgery | UC Cincinnati College of ... - September 25th, 2018 [September 25th, 2018]
- Cardiothoracic surgery - Wikipedia - September 25th, 2018 [September 25th, 2018]
- Cardiac Surgery | NorthShore - September 25th, 2018 [September 25th, 2018]
- Open Heart Surgery - Cardiac Surgery - University of ... - September 25th, 2018 [September 25th, 2018]
- Heart Surgery | Cleveland Clinic - September 25th, 2018 [September 25th, 2018]
- Cardiac Surgery - Ventricular Assist Devices (VAD) - October 4th, 2018 [October 4th, 2018]
- VCSQI | Virginia Cardiac Services Quality Initiative ... - October 12th, 2018 [October 12th, 2018]
- Cardiac Surgery | Boston Medical Center - October 15th, 2018 [October 15th, 2018]
- Cardiac Surgery | WVU Heart and Vascular Institute - November 10th, 2018 [November 10th, 2018]
- Cardiac Surgery - Heart Valve, Bypass | GW Hospital - November 13th, 2018 [November 13th, 2018]
- Cardiac Surgery - Department of Surgery - University of ... - November 29th, 2018 [November 29th, 2018]
- Cardiac Surgery - Jersey Shore University Medical Center - December 7th, 2018 [December 7th, 2018]
- Blunt Cardiac Injury - The American Association for the ... - December 20th, 2018 [December 20th, 2018]
- Minimally invasive cardiac surgery - Wikipedia - December 20th, 2018 [December 20th, 2018]
- Heart Surgery | Private cardiac specialists in London ... - December 20th, 2018 [December 20th, 2018]
- Cardiac Surgery - Waterbury Hospital - December 20th, 2018 [December 20th, 2018]
- Cardiac surgery - Wikipedia - December 25th, 2018 [December 25th, 2018]
- Heart Surgery | Memorial Healthcare System - December 31st, 2018 [December 31st, 2018]
- A Step-By-Step Look at Open Heart Bypass Surgery - December 31st, 2018 [December 31st, 2018]
- Cardiac Surgery - Erlanger - December 31st, 2018 [December 31st, 2018]
- Inova Cardiac and Thoracic Surgery | Northern VA & DC - Inova - March 6th, 2019 [March 6th, 2019]
- Cardiac Surgery | Heart and Vascular Center | Dartmouth ... - March 13th, 2019 [March 13th, 2019]
- Cardiovascular Medicine and Cardiac Surgery - April 1st, 2019 [April 1st, 2019]
- Minimally invasive heart surgery - Mayo Clinic - April 3rd, 2019 [April 3rd, 2019]
- Home > Cardiac Surgery | Surgery | Yale School of Medicine - April 16th, 2019 [April 16th, 2019]
- Heart and Vascular Care Services - UR Medicine, University ... - April 18th, 2019 [April 18th, 2019]
- Welcome! | LHSC - April 20th, 2019 [April 20th, 2019]
- Cardiac Surgery | Department of Surgery | The University ... - April 20th, 2019 [April 20th, 2019]
- Coronary bypass surgery - Mayo Clinic - April 23rd, 2019 [April 23rd, 2019]
- Cardiovascular Surgery - Overview - Mayo Clinic - April 23rd, 2019 [April 23rd, 2019]
- Cardiac Surgery | McLaren Health Care - April 23rd, 2019 [April 23rd, 2019]
- Volunteer opens heart to his faith after healing cardiac ... - April 23rd, 2019 [April 23rd, 2019]
- Heart Surgery - UChicago Medicine - April 27th, 2019 [April 27th, 2019]
- Heart Surgery | UM St. Joseph Medical Center - May 13th, 2019 [May 13th, 2019]
- Cardiac Surgery - Billings Clinic - May 13th, 2019 [May 13th, 2019]
- Cardiology and Cardiac Surgery - Chicago Cardiologists and ... - May 23rd, 2019 [May 23rd, 2019]
- Cardiac Surgery | Michigan Medicine | University of Michigan - September 11th, 2019 [September 11th, 2019]
- Guidelines for Perioperative Care in Cardiac Surgery ... - September 11th, 2019 [September 11th, 2019]
- Cannula Market To Flourish And Reach USD 433 Million By 2025 - ZMR News Network - October 4th, 2019 [October 4th, 2019]
- Heart Health: Dr Panda says one should never give up on a patient - Republic World - October 4th, 2019 [October 4th, 2019]
- Minimally Invasive Surgery Market 2024 By Manufacturers, Investment Feasibility, Cost Structure And Swot Analysis - The Washington Observer - October 4th, 2019 [October 4th, 2019]
- Michael Schumacher health latest: What is stem cell therapy and how will it help Schumi? - Express.co.uk - October 4th, 2019 [October 4th, 2019]
- Cooperative insurance: Novel financing model aims to deliver healthcare to the middle-class segment - The Hindu BusinessLine - October 4th, 2019 [October 4th, 2019]
- Optimism Linked to Lower Risk of Cardiovascular Events and Death - Cath Lab Digest - October 4th, 2019 [October 4th, 2019]
- Global Cardiac Surgery Devices Market 2019 Innovative Trends and Insights Research upto 2024 - Markets Gazette - October 4th, 2019 [October 4th, 2019]
- Abiomed Receives FDA PMA Approval for Impella 5.5 With SmartAssist - Diagnostic and Interventional Cardiology - October 4th, 2019 [October 4th, 2019]
- Economics of Cochlear Implant Utilization : The Hearing Journal - LWW Journals - October 4th, 2019 [October 4th, 2019]
- How to Keep the Weight Off After Bariatric Surgery - Health Essentials from Cleveland Clinic - October 4th, 2019 [October 4th, 2019]
- Heart Lung Machine Market to Upsurge at 6.13% CAGR by 2023, Owing to Increasing Demand From the Healthcare Sector: Radiant Insights, Inc. - PRNewswire - October 4th, 2019 [October 4th, 2019]
- Annadale toddler born with rare condition is fighting for her life - SILive.com - October 4th, 2019 [October 4th, 2019]
- Ocala Health earns distinction, ranks among top within HCA open heart programs - Ocala News - October 4th, 2019 [October 4th, 2019]
- External Validation Of The Surgical Mortality Probability Model (S-MPM | TCRM - Dove Medical Press - October 4th, 2019 [October 4th, 2019]
- CytoSorb Removal of Ticagrelor Intraoperatively Results in Projected Cost Savings of Approximately $5,000 in Each Patient Undergoing Emergency Cardiac... - October 4th, 2019 [October 4th, 2019]
- Senior Lecturer/Associate Professor in Medical Statistics job with UNIVERSITY OF BRISTOL | 183393 - Times Higher Education (THE) - October 15th, 2019 [October 15th, 2019]
- Complicated surgery at NICVD saves life of nine-year-old boy - The News International - October 15th, 2019 [October 15th, 2019]
- Angion Announces Several Strategic Additions to its Management Team to Support the Future Development and Commercialization of ANG-3777 - Yahoo... - October 15th, 2019 [October 15th, 2019]
- 'Sky is the limit' for heart treatment without invasive surgery - Ottawa Citizen - October 15th, 2019 [October 15th, 2019]
- Executive Profile: Dr. David Anschel - Long Island Business News - October 15th, 2019 [October 15th, 2019]
- Heart surgeon and author reveals how he once set fire to patient - The Guardian - October 15th, 2019 [October 15th, 2019]
- Demolition paves way for heart, vascular center - Midland Daily News - October 15th, 2019 [October 15th, 2019]
- The basics of research | TNS - The News on Sunday - October 15th, 2019 [October 15th, 2019]
- Senior Lecturer/Associate Professor in Medical Statistics job with UNIVERSITY OF BRISTOL | 183345 - Times Higher Education (THE) - October 15th, 2019 [October 15th, 2019]
- Sparks, Accusations Fly Over Conduct of EXCEL Trial - Medscape - October 15th, 2019 [October 15th, 2019]
- More Heart Valve Patients May Choose Minimally Invasive Procedure - Newswise - October 15th, 2019 [October 15th, 2019]
- 'Words cannot begin to describe the pain': Parents discover baby has tumour on heart - Bristol Post - October 23rd, 2019 [October 23rd, 2019]